The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Facing Obstacles to RDI (Relative Dose Intensity) Through Telephone Intervention Strategy
Official Title: Facing Obstacles to RDI(Relative Dose Intensity)Through Telephone Intervention Strategy
Study ID: NCT01393366
Brief Summary: The investigators plan to conduct a nurse-based telephone intervention study to minimize toxicity and increase compliance to a combination of Fludarabine-Cyclophosphamide-Rituximab (FCR) given frontline to Chronic Lymphocytic Leukemia patients.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Centre Hospitalier de la côte basque, Bayonne, , France
CH Saint Jean, Perpignan, , France
CHU Purpan, Toulouse, , France
Name: Loïc YSEBAERT, MD
Affiliation: University Hospital Of Toulouse
Role: PRINCIPAL_INVESTIGATOR